TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Cash from Investing Activities (2020 - 2025)

TAO Synergies' (TAOX) quarterly Cash from Investing Activities came in at -$11.3 million in Q4 2025, up 13.36% quarter-over-quarter from -$13.1 million in Q3 2025.

Analysis

TAO Synergies (TAOX) Cash from Investing Activities (2020 - 2025) Analysis & Trends

TAO Synergies (TAOX) has reported Cash from Investing Activities for 5 consecutive years, with -$11.3 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$11.3 million; the trailing twelve-month figure through Dec 2025 stood at -$24.4 million (down 2339.47% YoY), and the FY2025 full-year result was -$28.9 million, down 2789.47% from the prior year.
  • Cash from Investing Activities grew to -$11.3 million in Q4 2025 per TAOX's latest filing, from -$13.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$669.0 in Q2 2023 and bottomed at -$13.1 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged -$3.0 million across 4 years, with a median of -$500000.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 93401.64% in 2023, then plunged 24433.86% in 2024.
  • Over 4 years, Cash from Investing Activities stood at -$2139.0 in 2022, then sank by 93401.64% to -$2.0 million in 2023, then soared by 75.0% to -$500000.0 in 2024, then slumped by 2164.9% to -$11.3 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$11.3 million, -$13.1 million, and -$500000.0 for Q4 2025, Q3 2025, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn -569.00 Mn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn -10.35 Bn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn -45.80 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn -92.70 Mn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn -
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn 329.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn -363.46 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn -3.84 Bn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn 281.26 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -11.32 Mn
Sep 30, 2025 -13.07 Mn
Jun 30, 2024 -500,000.00
Mar 31, 2024 -500,000.00
Dec 31, 2023 -2.00 Mn
Jun 30, 2023 -669.00
Mar 31, 2023 -2,038.00
Dec 31, 2022 -2,139.00
Sep 30, 2022 -2,246.00
Jun 30, 2020 -2,814.00
Mar 31, 2020 -2,599.00